Introduction
Systemic Sclerosis (SSc), or scleroderma, is a complex autoimmune disease characterized by multi-organ fibrosis. Among its various manifestations, pulmonary complications—specifically Interstitial Lung Disease (ILD) and Pulmonary Hypertension (PH)—are the leading causes of mortality. While Western cohorts have extensively documented the poor prognosis associated with concomitant PH and ILD (SSc-PH-ILD), data regarding multiethnic Asian populations remain limited. This study investigates the impact of these complications on survival and hospitalization rates within the Scleroderma Cohort Singapore.
Methods
This retrospective study analyzed 490 patients from three tertiary rheumatology institutions in Singapore between 2008 and 2016. Patients were stratified into four distinct groups based on pulmonary involvement:
- Isolated PH (n=50): Diagnosed via echocardiography (sPAP ≥ 50 mmHg) or right heart catheterization (mean PAP ≥ 25 mmHg).
- Isolated ILD (n=92): Confirmed by High-Resolution Computed Tomography (HRCT) and pulmonary function tests (FVC < 70%).
- Concomitant PH-ILD (n=43): Patients meeting criteria for both conditions.
- Neither (n=305): Control group without significant pulmonary involvement.
Multivariate stepwise Cox regression was employed to identify independent risk factors for mortality.
Survival Analysis
The study revealed significant differences in survival outcomes across the subgroups. Contrary to some Western findings where the concomitant PH-ILD group often faces the worst prognosis, this Singaporean cohort identified isolated PH as the primary driver of mortality.
The 5-year survival rates were 90% for isolated ILD, 87% for concomitant PH-ILD, and 79% for isolated PH. Multivariable analysis confirmed that PH was associated with a 2.8-fold increased risk of death. The survival curves (Figure 1) illustrate that patients with isolated PH experienced a more rapid decline in survival compared to those with ILD or neither condition.
Independent Risk Factors for Mortality
Beyond pulmonary complications, several clinical features were identified as significant independent predictors of mortality. These "red flags" provide crucial prognostic information for clinicians managing SSc.
As shown in Figure 3, malabsorption (HR 2.89) and male gender (HR 2.85) were the strongest non-pulmonary predictors of death. Digital ulcerations (HR 2.06) and renal crisis (HR 2.00) also significantly increased the hazard of mortality. Interestingly, while PH and ILD were major drivers of death, they did not significantly increase the annual rate of hospitalizations. Instead, hospital admissions were more frequently linked to acute events such as renal crisis and right heart failure.
Discussion and Conclusion
This study highlights the critical prognostic impact of PH in Asian SSc patients, where isolated PH appears to carry a higher mortality risk than isolated ILD or even concomitant PH-ILD. The identification of non-pulmonary risk factors like malabsorption and male gender underscores the need for a comprehensive, multi-system approach to patient monitoring.
Limitations of the study include a relatively small sample size in specific subgroups and a short follow-up duration for some participants. Future research is needed to explore the biological basis for the high mortality risk in males and the specific impact of malabsorption, as well as to understand the regional differences in PH-ILD outcomes compared to Western cohorts. These insights are vital for developing personalized management strategies for the multiethnic SSc population in Singapore.
Summary updated